YAP1 and breast cancer: These demonstrated that the Hippo/YAP/TAZ/TEAD axis may be a key contributor for phenotypic heterogeneity determining the invasiveness of the cells expressing different missense p53 mutations, in agreement with the reported role of TAZ in breast cancer development and aggressive phenotypes in cell/animal models62 and breast carcinomas63.